Hisamitsu Pharmaceutical Co., Inc.

HTSUY · OTC
Analyze with AI
2/28/2025
2/28/2024
2/28/2023
2/28/2022
Assets
Cash & Equivalents$759,932$360,266$480,300$748,834
Short-Term Investments$96,871$477,050$524,494$487,814
Receivables$311,085$287,185$291,840$330,905
Inventory$148,585$141,485$138,913$142,496
Other Curr. Assets$35,847$30,347$26,656$27,966
Total Curr. Assets$1,352,321$1,296,332$1,462,203$1,738,016
Property Plant & Equip (Net)$397,485$330,474$317,212$339,214
Goodwill$8,587$9,648$0$0
Intangibles$31,056$35,993$6,945$11,513
Long-Term Investments$399,628$448,460$446,684$455,993
Tax Assets$12,681$11,018$9,852$10,011
Other NC Assets$74,813$64,769$61,675$74,799
Total NC Assets$924,251$900,361$842,367$891,530
Other Assets$0$0$0$0
Total Assets$2,276,572$2,196,693$2,304,570$2,629,546
Liabilities
Payables$93,666$108,659$8,351,000$7,533,000
Short-Term Debt$9,781$359,494$1,398,000$1,372,000
Tax Payable$0$1,889,000$17,164$25,509
Deferred Revenue$19,005$30,327$43,461$25,509
Other Curr. Liab.$190,935-$2,080,551-$9,497,045-$8,676,791
Total Curr. Liab.$313,388$306,929$312,579$279,227
LT Debt$15,807$4,537$152,506$226,545
Deferred Rev, NC$0$4,029$5,506$7,545
Deferred Tax Liab, NC$28,561$30,186$1,813,000$4,170,000
Other NC Liab.$64,667$70,549$10,225,000$10,558,000
Total NC Liab.$109,035$105,272$94,916$137,261
Other Liabilities$0$0$0$0
Cap. Leases$4,566$354,029$332,506$308,545
Total Liabilities$422,423$412,200$407,496$416,488
Equity
Pref Stock$0$0$0$0
Common Stock$56,226$56,611$62,203$73,566
Retained Earnings$1,711,278$1,620,752$1,729,391$2,050,723
AOCI$347,191$323,726$272,767$222,887
Other Equity-$277,700-$231,349-$182,293-$149,060
Total Equity$1,836,995$1,769,740$1,882,069$2,198,116
Supplemental Information
Minority Interest$17,127$14,732$14,991$14,908
Total Liab. & Tot. Equity$2,276,572$2,196,673$2,304,555$2,629,512
Net Debt-$734,344$3,765$1,070,206$849,711